SPDR S&P Biotech (ETF) (AMEX:XBI)

CAPS Rating: 3 out of 5

Exchange traded funds

Recs

0
Player Avatar msamet1 (88.32) Submitted: 3/30/2007 10:56:18 AM : Underperform Start Price: $47.63 XBI Score: -74.52

Product revenue control for sector diluted by required big pharma marketing partner; profits diluted by cost containment/reimbursement

Report this Post Reply

Featured Broker Partners


Advertisement